L-dopa and favism.
D004295:Dihydroxyphenylalanine / Q000009:adverse effects* / Q000627:therapeutic use; D005236:Favism / Q000139:chemically induced*; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000150:complications*; D006461:Hemolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy
D004295:Dihydroxyphenylalanine